Described herein are pharmaceutical packaging methods which avert oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive prescription drugs, these units together with a syringe using an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with quite minimal permeability